Tower Research Capital (TRC)’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.14K Buy
907
+341
+60% +$2.33K ﹤0.01% 3984
2025
Q4
$3.1K Sell
566
-707
-56% -$3.64K ﹤0.01% 4423
2025
Q3
$5.08K Buy
1,273
+355
+39% +$1.49K ﹤0.01% 4268
2025
Q2
$2.48K Buy
918
+269
+41% +$713 ﹤0.01% 4646
2025
Q1
$3.4K Buy
649
+195
+43% +$1.23K ﹤0.01% 4418
2024
Q4
$3.49K Buy
454
+21
+5% +$176 ﹤0.01% 4649
2024
Q3
$4.05K Sell
433
-1,214
-74% -$11.7K ﹤0.01% 4701
2024
Q2
$17.7K Buy
1,647
+632
+62% +$8.56K ﹤0.01% 3826
2024
Q1
$15K Buy
1,015
+551
+119% +$7.68K ﹤0.01% 3267
2023
Q4
$8.86K Buy
464
+128
+38% +$3.13K ﹤0.01% 4455
2023
Q3
$9.05K Buy
336
+143
+74% +$6.19K ﹤0.01% 4274
2023
Q2
$8.73K Sell
193
-64
-25% -$3.14K ﹤0.01% 4379
2023
Q1
$12K Buy
257
+124
+93% +$6.41K ﹤0.01% 4117
2022
Q4
$7K Sell
133
-264
-66% -$15.6K ﹤0.01% 4608
2022
Q3
$46K Buy
397
+154
+63% +$13.7K ﹤0.01% 3243
2022
Q2
$15K Buy
243
+79
+48% +$5.94K ﹤0.01% 4087
2022
Q1
$9K Sell
164
-165
-50% -$13.7K ﹤0.01% 4483
2021
Q4
$25K Buy
329
+270
+458% +$31.4K ﹤0.01% 3434
2021
Q3
$8K Buy
+59
New +$6.92K ﹤0.01% 4558

Other funds holding RLYB

Tower Research Capital (TRC)'s RLYB Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Rallybio (RLYB) stake by 60% in Q1 2026, buying an estimated $2.33K and bringing the position to 907 shares worth $8.14K. The position accounts for ﹤0.01% of the portfolio, ranked #3984.

Tower Research Capital (TRC) first reported a position in RLYB in Q3 2021 and has held it in 19 quarters since. The position peaked at $46K in Q3 2022. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Tower Research Capital (TRC) held 907 shares of Rallybio worth $8.14K as of Q1 2026.
  • Tower Research Capital (TRC) bought 341 Rallybio shares in Q1 2026, an estimated $2.33K.
  • Rallybio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3984 holding.
  • Tower Research Capital (TRC) first reported a position in Rallybio in Q3 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Rallybio position peaked at $46K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.